TrialInflammopharmacology2025

The effects of ellagic acid in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: a randomized, add-on, double-blind, controlled trial.

Mohammad Mahmoudi Azar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.